TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 31746501

Group type: EXPERIMENTAL
Intervention: Questionnaire-based survey
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Mystery client survey
Number of subjects: 165

Group type: COMPARATOR
Intervention: Comparison of both surveys
Number of subjects: 165
Study: 28744557

Group type: EXPERIMENTAL
Intervention: Active pulsed magnetic stimulation (PMS) for 8 weeks (twice/week)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Sham pulsed magnetic stimulation for 8 weeks (twice/week)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Both groups (Active and Sham)
Number of subjects: 120
Study: 26070435

Group type: EXPERIMENTAL
Intervention: Computer-aided impression with Lava C.O.S. (CAI)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Conventional polyether impression with Impregum pent soft (CI)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: CAI
Number of subjects: 25

Group type: COMPARATOR
Intervention: CI
Number of subjects: 25
Study: 25079861

Group type: EXPERIMENTAL
Intervention: Colestilan 3 - 12 g/day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Simvastatin 10 - 40 mg/day
Number of subjects: 0

Group type: COMPARATOR
Intervention: Colestilan
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 22271472

Group type: COMPARATOR
Intervention: Paclitaxel and carboplatin with thoracic radiation (PC)
Number of subjects: 546

Group type: EXPERIMENTAL
Intervention: Paclitaxel and carboplatin with thoracic radiation plus thalidomide (TPC)
Number of subjects: 546
Study: 20190064

Group type: EXPERIMENTAL
Intervention: Telemedicine case management
Number of subjects: 1665

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1665
Study: 17919359

Group type: EXPERIMENTAL
Intervention: Preoperative use of thiazolidinediones (TZDs)
Number of subjects: 184

Group type: COMPARATOR
Intervention: No preoperative use of thiazolidinediones (TZDs)
Number of subjects: 184
Study: 15863540

Group type: EXPERIMENTAL
Intervention: Preoperative vaginal preparation with povidone-iodine
Number of subjects: 308

Group type: COMPARATOR
Intervention: Standard abdominal scrub alone (Control)
Number of subjects: 308
Study: 11967501

Group type: EXPERIMENTAL
Intervention: Isosorbide 5‐mononitrate 40 mg 4 hours or 10 hours before the operation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (no preoperative treatment)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Isosorbide 5‐mononitrate 40 mg
Number of subjects: 0
Study: 9847262

Group type: EXPERIMENTAL
Intervention: Single-breath diffusing capacity for carbon monoxide (DL(CO)) test
Number of subjects: 1275
Study: 7715343

Group type: EXPERIMENTAL
Intervention: Hepatitis B vaccination
Number of subjects: 261

Group type: COMPARATOR
Intervention: Chronic HBsAg carriers
Number of subjects: 261
Study: 2757664

Group type: EXPERIMENTAL
Intervention: Acetylsalicylic acid sustained release formulation (Contrheuma retard) 300 mg initial dose and 350 mg retard formulation
Number of subjects: 6

Group type: COMPARATOR
Intervention: Standard ASA solution for intravenous administration
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Acetylsalicylic acid sustained release formulation (Contrheuma retard)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Comparison of both formulations
Number of subjects: 6

Group type: COMPARATOR
Intervention: Comparison of mean time for SA
Number of subjects: 6
Study: 337694

Group type: EXPERIMENTAL
Intervention: Novocain treatment (2% procain 5ml, intramuscular injections, 3 times a week, 12 injections a month)
Number of subjects: 173

Group type: EXPERIMENTAL
Intervention: Gerovital H3 treatment according to A. Aslan's method
Number of subjects: 173

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 173
Study: 7030048

Group type: EXPERIMENTAL
Intervention: 18% sucrose diet
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 33% sucrose diet
Number of subjects: 24

Group type: COMPARATOR
Intervention: 5% sucrose diet
Number of subjects: 24
Study: 30755016

Group type: EXPERIMENTAL
Intervention: Aerobic interval training
Number of subjects: 167

Group type: EXPERIMENTAL
Intervention: Continuous training
Number of subjects: 167

Group type: COMPARATOR
Intervention: Exercise non-responders (defined as change in peak oxygen uptake <1 ml/kg/min)
Number of subjects: 167

Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 167

Group type: EXPERIMENTAL
Intervention: History of elective percutaneous coronary intervention
Number of subjects: 167

Group type: EXPERIMENTAL
Intervention: Higher baseline peak oxygen uptake
Number of subjects: 167

Group type: EXPERIMENTAL
Intervention: Training intensity
Number of subjects: 167

Group type: EXPERIMENTAL
Intervention: Baseline physical activity
Number of subjects: 167

Group type: EXPERIMENTAL
Intervention: Oxygen uptake efficiency slope
Number of subjects: 167
Study: 28929527

Group type: EXPERIMENTAL
Intervention: Music exposure during the first six hours of a 12-hour observation period
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Music exposure during the last six hours of a 12-hour observation period
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (no music exposure)
Number of subjects: 30
Study: 26770664

Group type: EXPERIMENTAL
Intervention: D-cycloserine (50 mg) given 30 minutes prior to weekly group social skills training for 10 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo given 30 minutes prior to weekly group social skills training for 10 weeks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both D-cycloserine and placebo (entire group)
Number of subjects: 0
Study: 25132784

Group type: EXPERIMENTAL
Intervention: 4-L sulfa-free polyethylene glycol (4-L SF-PEG)
Number of subjects: 206

Group type: COMPARATOR
Intervention: 2-L polyethylene glycol solution with ascorbic acid (2-L PEG + Asc)
Number of subjects: 206
Study: 22556186

Group type: EXPERIMENTAL
Intervention: Personal health record (PHR)‐linked medications module
Number of subjects: 541

Group type: COMPARATOR
Intervention: Control group with a different PHR‐linked intervention
Number of subjects: 541
Study: 19173689

Group type: EXPERIMENTAL
Intervention: Magnesium sulfate 50 mg
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Fentanyl 25 microg
Number of subjects: 90

Group type: COMPARATOR
Intervention: Saline (placebo) 0.9% sodium chloride
Number of subjects: 90
Study: 17253995

Group type: EXPERIMENTAL
Intervention: Partial body-weight-supported treadmill training (PBWSTT), conducted twice a week for 6 weeks
Number of subjects: 14
Study: 16022849

Group type: EXPERIMENTAL
Intervention: Mifepristone 10 mg (3 courses) with condoms
Number of subjects: 2000

Group type: COMPARATOR
Intervention: Condoms only (Control)
Number of subjects: 2000
Study: 12372311

Group type: EXPERIMENTAL
Intervention: Deloading tape
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo sham tape
Number of subjects: 24

Group type: COMPARATOR
Intervention: No-tape control
Number of subjects: 24
Study: 9832286

Group type: EXPERIMENTAL
Intervention: Cefepime (2 g intravenously every 12 h)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Ceftazidime (2 g intravenously every 8 h)
Number of subjects: 40
Study: 7858479

Group type: EXPERIMENTAL
Intervention: Folic acid supplementation (10 mg/day)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 32

Group type: COMPARATOR
Intervention: Patients with adenomas
Number of subjects: 32
Study: 2627107

Group type: EXPERIMENTAL
Intervention: Alpress osmotic tablet (prazosin)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Standard prazosin
Number of subjects: 48
Study: 825744

Group type: EXPERIMENTAL
Intervention: Calcium in combination with vitamin D2 (calciferol), given orally
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 30808203

Group type: EXPERIMENTAL
Intervention: Healthy lifestyle intervention (brief advice and referral to a six-month telephone-based coaching service)
Number of subjects: 280
Study: 28012663

Group type: EXPERIMENTAL
Intervention: Inhaled corticosteroids (ICSs)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 25645164

Group type: EXPERIMENTAL
Intervention: Parent-augmented One-Session Treatment (A-OST)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Child-focused One-Session Treatment (OST)
Number of subjects: 97
Study: 24423417

Group type: EXPERIMENTAL
Intervention: 68.8 mg lidocaine with 50 μg epinephrine plus 0.9 M mannitol (5 mL formulation)
Number of subjects: 40

Group type: COMPARATOR
Intervention: 68.8 mg lidocaine with 50 μg epinephrine (1.72 mL formulation)
Number of subjects: 40
Study: 22233822

Group type: EXPERIMENTAL
Intervention: Mitomycin C (MC) at 10 or 20 mg/m² every 3 weeks
Number of subjects: 38
Study: 19299753

Group type: EXPERIMENTAL
Intervention: 12-week dragon boat physical activity intervention
Number of subjects: 8
Study: 17879121

Group type: EXPERIMENTAL
Intervention: Consultation including genetic information
Number of subjects: 294

Group type: EXPERIMENTAL
Intervention: Consultation not including genetic information
Number of subjects: 294

Group type: COMPARATOR
Intervention: Control group (no consultation)
Number of subjects: 294
Study: 15586886

Group type: COMPARATOR
Intervention: G0-micronucleus (MN) assay with low dose-rate (LDR) irradiation (4 mGy/min)
Number of subjects: 0

Group type: COMPARATOR
Intervention: G0-micronucleus (MN) assay with high dose-rate (HDR) irradiation (1 Gy/min)
Number of subjects: 0

Group type: COMPARATOR
Intervention: G2 assay with 0.4 Gy 60Co gamma rays
Number of subjects: 0

Group type: COMPARATOR
Intervention: G0-micronucleus (MN) assay
Number of subjects: 0

Group type: COMPARATOR
Intervention: Dose-rate sparing index
Number of subjects: 0
Study: 11189924

Group type: EXPERIMENTAL
Intervention: Conservative treatment
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Surgical treatment
Number of subjects: 48
Study: 9185430

Group type: EXPERIMENTAL
Intervention: Transdermal fentanyl
Number of subjects: 202

Group type: COMPARATOR
Intervention: Sustained-release oral morphine
Number of subjects: 202
Study: 1489037

Group type: EXPERIMENTAL
Intervention: 75 mg diclofenac (intramuscular)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 3930688

Group type: EXPERIMENTAL
Intervention: Liposyn at 0.34 g
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Liposyn at 0.68 g
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Modified Liposyn at 0.68 g/kg/day
Number of subjects: 0

Group type: COMPARATOR
Intervention: Reference group (fat-free parenteral nutrition)
Number of subjects: 0
Study: 28292339

Group type: EXPERIMENTAL
Intervention: Ferric sulfate with mineral trioxide aggregate (FS+MTA) pulpotomy
Number of subjects: 70

Group type: COMPARATOR
Intervention: Root canal therapy (RCT)
Number of subjects: 70
Study: 25884981

Group type: EXPERIMENTAL
Intervention: Medium dose: 50 mg Zn, 75 mcg Se, 250 IU vitamin E
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Low dose: 25 mg Zn, 50 mcg Se, 250 IU vitamin E
Number of subjects: 150

Group type: COMPARATOR
Intervention: Standard supplement (control)
Number of subjects: 150
Study: 23720186

Group type: EXPERIMENTAL
Intervention: Smoking-related cues (smoking images in study 1; cigarette cue-exposure task in study 2)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Neutral cues (neutral images in study 1; drinking-straw task in study 2)
Number of subjects: 51
Study: 22080020

Group type: EXPERIMENTAL
Intervention: 150 mg/kg PFA
Number of subjects: 528

Group type: EXPERIMENTAL
Intervention: 750 mg/kg PFA
Number of subjects: 528

Group type: EXPERIMENTAL
Intervention: 1,500 mg/kg PFA
Number of subjects: 528

Group type: COMPARATOR
Intervention: Control diet without PFA
Number of subjects: 528
Study: 18645554

Group type: EXPERIMENTAL
Intervention: Telemetry monitoring during laparoscopic cholecystectomy
Number of subjects: 21
Study: 16563323

Group type: EXPERIMENTAL
Intervention: Remifentanil 1 microg/kg
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 12556604

Group type: COMPARATOR
Intervention: Cognitive-behavioral group psychotherapy alone (N=103)
Number of subjects: 199

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral group psychotherapy supplemented by clinical case management (N=96)
Number of subjects: 199
Study: 10680104

Group type: EXPERIMENTAL
Intervention: Thiopental 2.5 +/- 1.0 mg/kg
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Propofol 1.6 +/- 0.6 mg/kg
Number of subjects: 40

Group type: COMPARATOR
Intervention: Thiopental
Number of subjects: 40

Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 40

Group type: COMPARATOR
Intervention: Thiopental and Propofol
Number of subjects: 40
Study: 9102587

Group type: EXPERIMENTAL
Intervention: Trachlight intubation
Number of subjects: 66

Group type: COMPARATOR
Intervention: Direct laryngoscopy
Number of subjects: 66
Study: 1712323

Group type: EXPERIMENTAL
Intervention: Mifepristone, 25 mg five times at 12-hour intervals (n = 192)
Number of subjects: 385

Group type: EXPERIMENTAL
Intervention: Mifepristone, 600 mg as a single dose (n = 193)
Number of subjects: 385
Study: 6179101

Group type: EXPERIMENTAL
Intervention: Indobufen (100 mg i.v.)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 31673775

Group type: EXPERIMENTAL
Intervention: Lenalidomide maintenance after ASCT
Number of subjects: 80
Study: 29092713

Group type: EXPERIMENTAL
Intervention: Group Family Nurse Partnership (gFNP)
Number of subjects: 166

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 166
Study: 27513257

Group type: EXPERIMENTAL
Intervention: Lidocaine with epinephrine plus ketamine (Group K)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Lidocaine with epinephrine (Group L)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Physiological saline solution with epinephrine (Group S)
Number of subjects: 90
Study: 25167690

Group type: EXPERIMENTAL
Intervention: Micronutrient supplementation (MMS) 'Sprinkles' (powdered formulation of iron, vitamins A and C, folic acid, and zinc)
Number of subjects: 621

Group type: EXPERIMENTAL
Intervention: Micronutrient supplementation (MMS) 'Sprinkles'
Number of subjects: 621

Group type: COMPARATOR
Intervention: Control (liquid iron and vitamins A and D)
Number of subjects: 621

Group type: EXPERIMENTAL
Intervention: Micronutrient supplementation (MMS) 'Sprinkles' and Control
Number of subjects: 621
Study: 22297671

Group type: EXPERIMENTAL
Intervention: Healthy volunteers
Number of subjects: 19

Group type: COMPARATOR
Intervention: Uric acid stone formers
Number of subjects: 19
Study: 20642549

Group type: EXPERIMENTAL
Intervention: Ticagrelor 100 mg twice daily
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Ticagrelor 300 mg once daily
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Ticagrelor 50-600 mg once daily
Number of subjects: 48

Group type: COMPARATOR
Intervention: Clopidogrel
Number of subjects: 48
Study: 18095612

Group type: EXPERIMENTAL
Intervention: Domestic Acarbose capsule (DAC)
Number of subjects: 179

Group type: COMPARATOR
Intervention: Glucoby
Number of subjects: 179
Study: 15735805

Group type: EXPERIMENTAL
Intervention: Triple antiplatelet therapy (Aspirin, Clopidogrel, Dipyridamole - ACD)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Combination of Aspirin and Clopidogrel (AC)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Aspirin, Clopidogrel, Dipyridamole (ACD)
Number of subjects: 22
Study: 11850324

Group type: EXPERIMENTAL
Intervention: Web-based tutorials only (Computer)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Lectures supplemented with Web-based tutorials (Both)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Traditional lecture format (Lecture)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: All formats (Computer, Both, Lecture)
Number of subjects: 32
Study: 9851729

Group type: EXPERIMENTAL
Intervention: High-dose intravenous immunoglobulin (IVIg) in patients with DM
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High-dose intravenous immunoglobulin (IVIg) in patients with IBM
Number of subjects: 0

Group type: COMPARATOR
Intervention: High-dose intravenous immunoglobulin (IVIg) in specific muscle groups in IBM patients
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional therapies in patients with DM
Number of subjects: 0

Group type: COMPARATOR
Intervention: Uncontrolled trials in PM
Number of subjects: 0
Study: 10393600

Group type: EXPERIMENTAL
Intervention: Nebulizer
Number of subjects: 17

Group type: COMPARATOR
Intervention: pMDI with holding chamber
Number of subjects: 17
Study: 2050832

Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide (HC) 72 +/- 26 mg/d
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Spironolactone (SP) 144 +/- 53 mg/d
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 6846677

Group type: EXPERIMENTAL
Intervention: Intensive group treatment procedures
Number of subjects: 93

Group type: COMPARATOR
Intervention: Individual counseling
Number of subjects: 93
Study: 30001258

Group type: EXPERIMENTAL
Intervention: High-dose folic acid (5 mg/wk)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Low-dose folic acid (0.8 mg/wk)
Number of subjects: 40
Study: 29482433

Group type: EXPERIMENTAL
Intervention: Dengvaxia (tetravalent live-attenuated 3-dose vaccine composed of chimeras of yellow fever 17D and the four dengue viruses)
Number of subjects: 35000
Study: 24998405

Group type: EXPERIMENTAL
Intervention: Conservative management without physical therapy
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Patients with ankle sprains
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Pain
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Deficits in muscle strength of dorsiflexors
Number of subjects: 30
Study: 23758981

Group type: EXPERIMENTAL
Intervention: Arthroscopic subacromial decompression surgery with application of PRP
Number of subjects: 0

Group type: COMPARATOR
Intervention: Arthroscopic subacromial decompression surgery
Number of subjects: 0
Study: 21623342

Group type: EXPERIMENTAL
Intervention: Demand-only PCEA (0.125% levobupivacaine plus 1.5 mcg/mL fentanyl, 10 mL bolus with a 20 min lock time)
Number of subjects: 40

Group type: COMPARATOR
Intervention: PCEA plus background infusion (10 mL/h)
Number of subjects: 40
Study: 19874650

Group type: EXPERIMENTAL
Intervention: 1.6 mg/kg oral MDMA
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 1.0 mg/kg oral MDMA
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 17032096

Group type: EXPERIMENTAL
Intervention: Forgiveness Therapy (FT)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Alternative Treatment (AT)
Number of subjects: 20
Study: 15068419

Group type: EXPERIMENTAL
Intervention: L. brevis (CD2)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 10647315

Group type: EXPERIMENTAL
Intervention: L‐NMMA (6 mg/kg intravenous infusion)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 8618603

Group type: EXPERIMENTAL
Intervention: Oral ganciclovir (1000 mg three times daily)
Number of subjects: 725

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 725
Study: 1610712

Group type: EXPERIMENTAL
Intervention: 1% crude coal tar used twice daily for 10 days
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Incremental regimen starting at 5% and increasing by 5% every second day to a maximum of 25%
Number of subjects: 20

Group type: COMPARATOR
Intervention: 5% crude coal tar
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Incremental regimen starting at 5%
Number of subjects: 20
Study: 6705284

Group type: EXPERIMENTAL
Intervention: Oral prenalterol at doses of 20, 40, 100, and 200 mg daily for four weeks
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Oral prenalterol
Number of subjects: 10
Study: 30642068

Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP) from burn patients
Number of subjects: 0

Group type: COMPARATOR
Intervention: Platelet-rich plasma (PRP) from healthy volunteers
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Platelet count of PRP
Number of subjects: 0
Study: 30016948

Group type: EXPERIMENTAL
Intervention: Functional Task Exercise (FTE)
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: Preventive Physical Therapy (PPT)
Number of subjects: 155

Group type: COMPARATOR
Intervention: Control Group (Usual Care)
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: Comparison between FTE and PPT
Number of subjects: 155
Study: 26708510

Group type: EXPERIMENTAL
Intervention: Preadmission application of chlorhexidine gluconate, 2% with electronic alert (EA)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Preadmission application of chlorhexidine gluconate, 2% without electronic alert (no-EA)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Preadmission application of chlorhexidine gluconate, 2%
Number of subjects: 100
Study: 24528690

Group type: EXPERIMENTAL
Intervention: OM3‐FFA 2 g/d
Number of subjects: 399

Group type: EXPERIMENTAL
Intervention: OM3‐FFA 3 g/d
Number of subjects: 399

Group type: EXPERIMENTAL
Intervention: OM3‐FFA 4 g/d
Number of subjects: 399

Group type: COMPARATOR
Intervention: Control (olive oil [OO] 4 g/d)
Number of subjects: 399
Study: 23171601

Group type: EXPERIMENTAL
Intervention: Worry intervention (cognitive-behavioral treatment)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Standard care (treatment as usual)
Number of subjects: 150
Study: 20018249

Group type: EXPERIMENTAL
Intervention: Propranolol 80 mg
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 18274167

Group type: EXPERIMENTAL
Intervention: Iron-deficiency anemia
Number of subjects: 337
Study: 16286622

Group type: EXPERIMENTAL
Intervention: Targeted intervention (comprehensive vision restoration‐rehabilitation program including assistance in obtaining cataract surgery)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 28
Study: 12011946

Group type: EXPERIMENTAL
Intervention: Haloperidol combined with total sleep deprivation
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo combined with total sleep deprivation
Number of subjects: 10
Study: 10207545

Group type: COMPARATOR
Intervention: Zidovudine (ZDV) monotherapy
Number of subjects: 1280

Group type: COMPARATOR
Intervention: Zidovudine (ZDV) plus didanosine (ddI)
Number of subjects: 1280

Group type: COMPARATOR
Intervention: Zidovudine (ZDV) plus zalcitabine (ddC)
Number of subjects: 1280

Group type: COMPARATOR
Intervention: Zidovudine (ZDV) monotherapy and combination arms
Number of subjects: 1280

Group type: EXPERIMENTAL
Intervention: HIV RNA nadirs achieved
Number of subjects: 1280

Group type: EXPERIMENTAL
Intervention: Baseline HIV RNA levels adjusted for CD4 cell counts
Number of subjects: 1280

Group type: EXPERIMENTAL
Intervention: Minimum HIV RNA achieved in the first 16 weeks
Number of subjects: 1280

Group type: EXPERIMENTAL
Intervention: CD4 cell counts
Number of subjects: 1280